# US 2022/0031385 A1 · Automatically performing irreversible electroporation ablation during heart refractory period

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0031385 A1
- Document ID: US20220031385A1
- Status: Published application
- Kind: A1
- Application number: 16/940,767
- Filed: 2020-07-28
- Published: 2022-02-03
- Earliest claimed: 2020-07-28
- Assignees: Biosense Webster (Israel) Ltd.
- Applicants: Biosense Webster (Israel) Ltd.
- Inventors: Assaf Govari
- Web page: https://patentgrep.com/patent/US20220031385A1

## CPC

- A61B 18/1492: {having a flexible, catheter-like structure, e.g. for heart ablation (A61B18/1477 takes precedence)}
- A61B 5/318: Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B 5/36: Detecting PQ interval, PR interval or QT interval
- A61B 2017/00044: {Sensing electrocardiography, i.e. ECG}
- A61B 2017/00132: {Setting operation time of a device (A61B2017/00123 takes precedence)}
- A61B 2018/00351: {Heart}
- A61B 2018/00357: {Endocardium}
- A61B 2018/00577: {Ablation}
- A61B 2018/00613: {Irreversible electroporation}
- A61B 2018/00642: {with feedback, i.e. closed loop control}
- A61B 2018/00708: {switching the power on or off}
- A61B 2018/00839: {Bioelectrical parameters, e.g. ECG, EEG}
- A61B 2018/126: {bipolar}
- A61B 2018/1467: {using more than two electrodes on a single probe}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A method includes inserting an ablation catheter into an ablation site in a patient heart. Multiple electrocardiogram (ECG) signals are acquired. A refractory period of the patient heart is detected based on the acquired ECG signals. The ablation site is ablated using the ablation catheter during the detected refractory period.

## Claims

### Claim 1

A method for performing irreversible electroporation during heart refractory period, the method comprising:
inserting an ablation catheter into an ablation site in a patient heart;
acquiring multiple electrocardiogram (ECG) signals;
detecting, based on the acquired ECG signals, a refractory period of the patient heart; and
ablating the ablation site using the ablation catheter during the detected refractory period.

### Claim 2 (depends on 1)

The method according to claim 1, wherein acquiring the multiple ECG signals comprises acquiring at least one of (i) intra-cardiac (IC) ECG signals at the ablation site, and (ii) body-surface (BS) ECG signals.

### Claim 3 (depends on 1)

The method according to claim 1, wherein detecting the refractory period comprises indicating a sinus rhythm in at least one of the acquired ECG signals.

### Claim 4 (depends on 1)

The method according to claim 1, wherein ablating the ablation site comprises applying one or more irreversible electroporation (IRE) pulses to tissue at the ablation site during the detected refractory period.

### Claim 5 (depends on 4)

The method according to claim 4, wherein applying the one or more IRE pulses comprises controlling an IRE pulse generator and applying the IRE pulses to the tissue in response to receiving at least one of the ECG signals that is indicative of the sinus rhythm.

### Claim 6

A system for performing irreversible electroporation during heart refractory period, the system comprising:
one or more electrodes, which are configured to sense multiple electrocardiogram (ECG) signals of a patient heart; and
a processor, which is configured, based on the acquired ECG signals, to detect a refractory period of the patient heart, and to control ablation at an ablation site during the detected refractory period.

### Claim 7 (depends on 6)

The system according to claim 6, wherein the electrodes comprise: (i) at least a first electrode fitted on a catheter and configured to sense intra-cardiac (IC) ECG signals at the ablation site, and (ii) second electrodes coupled to a surface of the patient, and configured to sense body-surface (BS) ECG signals of the patient heart.

### Claim 8 (depends on 6)

The system according to claim 6, wherein the processor is configured to detect the refractory period based on at least one of the ECG signals, which is indicative of a sinus rhythm pulse.

### Claim 9 (depends on 6)

The system according to claim 6, and comprising an irreversible electroporation (IRE) pulse generator, which is configured to apply IRE pulses to tissue at the ablation site during the detected refractory period.

### Claim 10 (depends on 9)

The system according to claim 9, wherein, in response to receiving at least one of the ECG signals that is indicative of a sinus rhythm pulse, the processor is configured to control the IRE pulse generator for applying the IRE pulses.

### Claim 11 (depends on 9)

The system according to claim 9, wherein the IRE pulse generator is configured to apply one or more bipolar IRE pulses between a pair of the electrodes, which are in contact with tissue at the ablation site.

### Claim 12 (depends on 6)

The system according to claim 6, wherein at least one of the one or more electrodes is fitted on a catheter and is configured to perform at least one of: (i) sensing intra-cardiac ECG signals at the ablation site, and (ii) applying one or more irreversible electroporation (IRE) pulses, to tissue at the ablation site.

### Claim 13

A system for performing irreversible electroporation during heart refractory period, the system comprising:
an interface, which is configured to receive multiple electrocardiogram (ECG) signals of a patient heart; and
a processor, which is configured, based on the received ECG signals, to detect a refractory period of the patient heart, and to control ablation at the ablation site during the detected refractory period.

### Claim 14 (depends on 13)

The system according to claim 13, wherein the interface is configured to receive at least one of (i) intra-cardiac (IC) ECG signals at the ablation site, and (ii) body-surface (BS) ECG signals.

### Claim 15 (depends on 13)

The system according to claim 13, wherein the processor is configured to detect the refractory period by indicating a sinus rhythm in at least one of the received ECG signals.

### Claim 16 (depends on 13)

The system according to claim 13, and comprising an irreversible electroporation (IRE) pulse generator, which is configured to apply IRE pulses to tissue at the ablation site during the detected refractory period.

### Claim 17 (depends on 16)

The system according to claim 16, wherein, in response to receiving at least one of the ECG signals that is indicative of a sinus rhythm pulse, the processor is configured to control the IRE pulse generator for applying the IRE pulses.

### Claim 18 (depends on 13)

The system according to claim 13, and comprising one or more electrodes, which are fitted on a catheter inserted into the ablation site of the patient heart, and are configured to perform at least one of: (i) sensing intra-cardiac ECG signals at the ablation site, and (ii) applying one or more irreversible electroporation (IRE) pulses, to tissue at the ablation site.
